DK0748319T3 - Fremgangsmåde til fremstilling af et epoxid - Google Patents
Fremgangsmåde til fremstilling af et epoxidInfo
- Publication number
- DK0748319T3 DK0748319T3 DK95911105T DK95911105T DK0748319T3 DK 0748319 T3 DK0748319 T3 DK 0748319T3 DK 95911105 T DK95911105 T DK 95911105T DK 95911105 T DK95911105 T DK 95911105T DK 0748319 T3 DK0748319 T3 DK 0748319T3
- Authority
- DK
- Denmark
- Prior art keywords
- epoxide
- preparing
- renin
- proteases
- synthesizing
- Prior art date
Links
- 150000002118 epoxides Chemical class 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 108010010369 HIV Protease Proteins 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 108090000783 Renin Proteins 0.000 abstract 1
- 102100028255 Renin Human genes 0.000 abstract 1
- -1 allyl acetonide Chemical compound 0.000 abstract 1
- 150000003944 halohydrins Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000376 reactant Substances 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20607494A | 1994-03-04 | 1994-03-04 | |
PCT/US1995/002347 WO1995023797A1 (en) | 1994-03-04 | 1995-02-27 | Process for making an epoxide |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0748319T3 true DK0748319T3 (da) | 2002-03-18 |
Family
ID=22764868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95911105T DK0748319T3 (da) | 1994-03-04 | 1995-02-27 | Fremgangsmåde til fremstilling af et epoxid |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0748319B1 (sv) |
JP (1) | JP3871705B2 (sv) |
KR (1) | KR100387741B1 (sv) |
CN (1) | CN1066728C (sv) |
AT (1) | ATE210662T1 (sv) |
AU (1) | AU690231B2 (sv) |
BR (1) | BR9506977A (sv) |
CA (1) | CA2183976C (sv) |
CZ (1) | CZ291816B6 (sv) |
DE (1) | DE69524578T2 (sv) |
DK (1) | DK0748319T3 (sv) |
ES (1) | ES2167419T3 (sv) |
FI (1) | FI120259B (sv) |
HR (1) | HRP950096B1 (sv) |
HU (1) | HU222750B1 (sv) |
MX (1) | MX9603871A (sv) |
NZ (1) | NZ281866A (sv) |
PT (1) | PT748319E (sv) |
RO (1) | RO117696B1 (sv) |
RU (1) | RU2137769C1 (sv) |
SK (1) | SK283067B6 (sv) |
TW (1) | TW380137B (sv) |
UA (1) | UA45968C2 (sv) |
WO (1) | WO1995023797A1 (sv) |
YU (1) | YU49010B (sv) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5728840A (en) * | 1994-03-04 | 1998-03-17 | Merck & Co., Inc. | Process for making an epoxide |
TW415948B (en) * | 1995-10-30 | 2000-12-21 | Merck & Co Inc | Process for synthesizing epoxide and halohydrin |
US5981759A (en) * | 1997-06-20 | 1999-11-09 | Merck & Co., Inc. | Process for indinavir intermediate |
NZ568068A (en) | 2005-11-09 | 2011-10-28 | Proteolix Inc | Compounds for enzyme inhibition |
SI2041158T1 (sl) | 2006-06-19 | 2013-09-30 | Onyx Therapeutics, Inc. | Peptidni epoksiketoni za inhibicijo proteasomov |
AU2008307510A1 (en) | 2007-10-04 | 2009-04-09 | Onyx Therapeutics, Inc. | Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
US20110236428A1 (en) | 2008-10-21 | 2011-09-29 | Onyx Therapeutics, Inc. | Combination therapy with peptide epoxyketones |
TWI504598B (zh) | 2009-03-20 | 2015-10-21 | Onyx Therapeutics Inc | 結晶性三肽環氧酮蛋白酶抑制劑 |
WO2011060179A1 (en) | 2009-11-13 | 2011-05-19 | Onyx Therapeutics, Inc | Use of peptide epoxyketones for metastasis suppression |
US9359398B2 (en) | 2010-03-01 | 2016-06-07 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
SG185103A1 (en) * | 2010-04-30 | 2012-12-28 | Univ Indiana Res & Tech Corp | Processes for preparing linezolid |
TW201414751A (zh) | 2012-07-09 | 2014-04-16 | 歐尼克斯治療公司 | 肽環氧酮蛋白酶抑制劑之前驅藥物 |
CN104692987B (zh) * | 2015-01-22 | 2017-05-17 | 北京大学 | 卤代醇及其衍生物的廉价高效合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2072237A1 (en) * | 1991-07-02 | 1993-01-03 | Merck & Co., Inc. | Stereoselective production of hydroxyamide compounds from chiral -amino epoxides |
SG52731A1 (en) * | 1991-11-08 | 1998-09-28 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids |
-
1995
- 1995-02-24 TW TW084101733A patent/TW380137B/zh not_active IP Right Cessation
- 1995-02-27 PT PT95911105T patent/PT748319E/pt unknown
- 1995-02-27 RO RO96-01750A patent/RO117696B1/ro unknown
- 1995-02-27 BR BR9506977A patent/BR9506977A/pt not_active IP Right Cessation
- 1995-02-27 CN CN95192714A patent/CN1066728C/zh not_active Expired - Lifetime
- 1995-02-27 EP EP95911105A patent/EP0748319B1/en not_active Expired - Lifetime
- 1995-02-27 MX MX9603871A patent/MX9603871A/es unknown
- 1995-02-27 AT AT95911105T patent/ATE210662T1/de active
- 1995-02-27 SK SK1122-96A patent/SK283067B6/sk not_active IP Right Cessation
- 1995-02-27 HU HU9602412A patent/HU222750B1/hu not_active IP Right Cessation
- 1995-02-27 NZ NZ281866A patent/NZ281866A/en not_active IP Right Cessation
- 1995-02-27 DK DK95911105T patent/DK0748319T3/da active
- 1995-02-27 WO PCT/US1995/002347 patent/WO1995023797A1/en active IP Right Grant
- 1995-02-27 DE DE69524578T patent/DE69524578T2/de not_active Expired - Lifetime
- 1995-02-27 ES ES95911105T patent/ES2167419T3/es not_active Expired - Lifetime
- 1995-02-27 CA CA002183976A patent/CA2183976C/en not_active Expired - Fee Related
- 1995-02-27 RU RU96120179A patent/RU2137769C1/ru not_active IP Right Cessation
- 1995-02-27 KR KR1019960704836A patent/KR100387741B1/ko not_active Expired - Fee Related
- 1995-02-27 UA UA96103798A patent/UA45968C2/uk unknown
- 1995-02-27 AU AU18828/95A patent/AU690231B2/en not_active Ceased
- 1995-02-27 CZ CZ19962543A patent/CZ291816B6/cs not_active IP Right Cessation
- 1995-02-27 JP JP52294995A patent/JP3871705B2/ja not_active Expired - Fee Related
- 1995-03-02 HR HR950096A patent/HRP950096B1/xx not_active IP Right Cessation
- 1995-03-03 YU YU14595A patent/YU49010B/sh unknown
-
1996
- 1996-09-03 FI FI963452A patent/FI120259B/sv not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0748319T3 (da) | Fremgangsmåde til fremstilling af et epoxid | |
NO910712D0 (no) | Fremgangsmaate ved fremstilling av oksetanoner. | |
YU27304A (sh) | Novi dihidropteridinoni, postupak za njihovo dobijanje i njihova primena kao lekova | |
PT931083E (pt) | Processo para a producao de compostos de ecteinascidina | |
LU91339I2 (fr) | Darunavir ou un sel, ester ou promédicament pharmaceutiquement acceptable de celui-ci (prezista) | |
UA50730C2 (uk) | Спосіб одержання 1-(тіометил)циклопропаноцтової кислоти та проміжних сполук для її одержання | |
WO2001057014A3 (en) | Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one | |
EA199800792A1 (ru) | Способы получения промежуточных соединений для пестицидов | |
ATE239716T1 (de) | Synthese von 3,6-dialkyl-5,6-dihydro-4-hydroxy-2h-pyran-2-on | |
YU45896A (sh) | Postupak za dobijanje epoksida | |
LV12825B (lv) | Hiv proteāzes inhibitora iegūšana | |
MX9300361A (es) | Derivado de 4-aril-3-heteroarilureidoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos. | |
YU55900A (sh) | Postupak za sintezu inhibitora hiv proteaze | |
HUP9903318A2 (hu) | Intermedierek taxol előállítására | |
DK1105392T3 (da) | Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin | |
GB2369356B (en) | Process | |
IT1309601B1 (it) | Processo per la preparazione di 1,4,7,10 tetraazaciclododecano. | |
ATE336493T1 (de) | Tricyclische epoxide | |
DK1331218T3 (da) | Fremgangsmåde til fremstilling af beskyttet 3-amino-1,2-dihydroxypropanacetal og derivater deraf | |
TW200611691A (en) | Retroviral protease inhibiting compounds | |
ATE188470T1 (de) | Chinolondisulfide als zwischenverbindungen | |
ATE247646T1 (de) | Herstellung von 2-ethyl-3-methyl-1,4-diazin | |
DK1268441T3 (da) | Mellemprodukt og fremgangsmåde til dets syntese |